Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY® in Multiple Markets Across Asia

Corium, LLC , a commercial-stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies, and Lotus Pharmaceutical , a multinational pharmaceutical...
-Today at 05:01 am- MarketScreener

Related Keywords

Japan ,Singapore ,Taiwan ,Hong Kong ,Thailand ,Malaysia ,Indonesia ,South Korea ,China ,Vietnam ,Republic Of ,Philippines ,Brazil ,Petar Vazharov ,Perry Sternberg ,Lotus ,Drug Administration ,Lotus Pharmaceutical ,License Agreement ,Chief Executive Officer ,Asia Pacific ,Important Safety Information ,Prescribing Information ,Cautionary Note ,Markets ,